WALTHAM, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Conjugate Group, a leading provider of Flexible Drug Development services, is proud to announce a full brand update, along with the launch of its new ...
The Phase I clinical trial for the adsorbed diphtheria, tetanus and acellular pertussis (components) Haemophilus Influenzae Type b (Conjugate)-Group ACYW135 Meningococcal (Conjugat... The Phase I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results